mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
6e-08 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.21 |
4e-05 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-05 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-05 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.25 |
7e-05 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0001 |